<SEC-DOCUMENT>0000920465-14-000124-index.html : 20141118
<SEC-HEADER>0000920465-14-000124.hdr.sgml : 20141118
<ACCEPTANCE-DATETIME>20141118165427
ACCESSION NUMBER:		0000920465-14-000124
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20141112
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20141118
DATE AS OF CHANGE:		20141118

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		141232503

	BUSINESS ADDRESS:	
		STREET 1:		4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4660 LA JOLLA VILLAGE DRIVE, SUITE 1070
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92122
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>q32014earningsrelease8-k.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: q32014earningsrelease8-k.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a991q32014pressrelease.htm
<DESCRIPTION>EXHIBIT
<TEXT>
Document 2 - file: a991q32014pressrelease.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>a992asnposterfinal.htm
<DESCRIPTION>EXHIBIT
<TEXT>
Document 3 - file: a992asnposterfinal.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>a993asnpressrelease.htm
<DESCRIPTION>EXHIBIT
<TEXT>
Document 4 - file: a993asnpressrelease.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>a992asnposterfinal001.jpg
<TEXT>
Document 5 - file: a992asnposterfinal001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ljpcpressrelease_image1.jpg
<TEXT>
Document 6 - file: ljpcpressrelease_image1.jpg

</DOCUMENT>
</SEC-DOCUMENT>